Author Archives: Peter Pitts

Memo to President Obama on Reforming FDA

By Peter Pitts | Published: January 21, 2009
In recent weeks, the incoming Obama administration has solicited input from across the policy community as it begins to shape priorities for its forthcoming term. As a former FDA official, I was honored to be asked for my advice on the pharma industry. Demand for drugs is on the rise, yet FDA remains undermanned, underfunded, and [...]
Posted in Regulatory | Tagged , , , , , , | Leave a comment

Asking the Right Questions on FDA Reform

By Peter Pitts | Published: January 7, 2009
When it comes to reforming the (FDA),if you don’t ask the right questions, you won’t get the right answers. Look at the recent media coverage of the agency’s 2008 drug approval numbers. Last year, the FDA approved more “first-of-their-kind” drugs (21) and instituted fewer “black box” warnings (46) than it did in 2007 (18 and 62, [...]
Posted in Regulatory | Tagged | Leave a comment